Autres langues JCR Pharmaceuticals Co., Ltd.

Actions

4552

JP3701000006

Temps Différé Japan Exchange Autres places de cotation 08:00:00 30/04/2024			Varia. 5j.	Varia. 1 janv.
815 ^JPY	+2,26 %		+0,87 %	-30,46 %

21/03	Les perspectives de taux d'intérêt de la Réserve fédérale américaine propulsent les actions japonaises à un nouveau sommet de 52 semaines	MT
19/03	JCR Pharmaceuticals Co. annonce le franchissement d'une étape importante dans l'utilisation de la technologie J-Brain Cargo pour les maladies neurodégénératives dans le cadre d'une collaboration de recherche avec Alexion	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak	21/03
JCR Pharmaceuticals Achieves Neurodegenerative Treatment Research Milestone With Alexion	21/03
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo Technology for Neurodegenerative Disease in Research Collaboration with Alexion	20/03
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion	19/03
JCR Pharmaceuticals Co., Ltd. Announces Achievement of Milestone Using J-Brain Cargo Technology for Neurodegenerative Disease in Research Collaboration with Alexion	19/03
JCR Pharmaceuticals Co., Ltd.(TSE:4552) dropped from FTSE All-World Index	18/03
Mycenax Biotech Inc. announced that it expects to receive funding from Center Laboratories, Inc., JCR Pharmaceuticals Co., Ltd., Taiwan BioVenture Company, Jason Technologies Ltd	13/03
JCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community	29/02
JCR Pharmaceuticals Co., Ltd. Announces Organizational and Personnel Changes	28/02
JCR Pharmaceuticals Research Presentations at WORLDSymposium 2024 Showcase JR-141 and Other Investigational Treatments for Lysosomal Storage Disorders	15/02
JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders	14/02
JCR Pharmaceuticals Co., Ltd. Presents Clinical Data on J-Brain Cargo®? to Deliver Medicines Across the Blood-Brain Barrier	14/02
JCR Pharmaceuticals Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	09/02
JCR Pharmaceuticals to Present at the 20th Annual WORLDSymposium™ 2024	25/01
JCR Pharmaceuticals and Takeda Pharmaceuticals Announce Discontinuation of Gene Therapy Collaboration	21/12
JCR Announces Research Collaboration, Option and License Agreement with Alexion on Discovery of Oligonucleotide Therapeutics Using J-Brain Cargo® Technology	21/12
Asia Markets Remain Mixed as Investors Step Back Following Rally	21/12
Japanese Shares Slip Back into Red as Wall Street Ends Winning Streak Ahead of Key US Data	21/12
JCR Pharmaceuticals' Partner Takeda to Scrap Gene Therapy Collaboration	21/12
JCR Pharmaceuticals Co., Ltd. and Takeda Pharmaceutical Co., Ltd. Announces Discontinuation of Gene Therapy Collaboration	20/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues JCR Pharmaceuticals Co., Ltd.

Actions

4552

JP3701000006

Autres langues

Filtres